Preclinical validation of PB002, a novel bacterial mix for the treatment of ulcerative colitis - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

40713.1 IP-LS

Project title

Preclinical validation of PB002, a novel bacterial mix for the treatment of ulcerative colitis

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-

Inserted texts

Category	Text
Short description (German)	Preclinical validation of PB002, a novel bacterial mix for the treatment of ulcerative colitis
Short description (English)	Preclinical validation of PB002, a novel bacterial mix for the treatment of ulcerative colitis
Abstract (German)	PharmaBiome is pioneering the development of next-generation microbiome therapies. To bridge the gap from proof of concept to the clinic we will validate the worldwide first co-cultivated microbiome product in relevant animal models of colitis as part of the preclinical studies.
Abstract (English)